Jump to navigation
Synthetic cannabinoids are more potent than cannabis and exhibit effects more typically associated with psychostimulants, a new study has found.
NDRI’s Social Studies of Addiction Concepts (SSAC) research team has produced a dedicated resource for information on performance and image enhancing drug (PIED) injecting.
Abstracts submissions are now being sought for the fifth biennial Contemporary Drug Problems conference in Italy from 4-6 September 2019.
The 2018 Postgraduate Research Symposium: Exploring Opportunities was held on Friday, 16 November at UNSW Sydney.
More than 250 attendees – including researchers, clinicians, colleagues and sector representatives from state and federal governments – joined us for the 2018 NDARC Annual Research Symposium.
Use of cocaine and higher purity forms of ecstasy and methamphetamine is increasing among samples of people who use drugs, according to the 2018 Drug Trends Reports.
A new NDARC report shows that 1,045 Australians aged 15-64 died of an opioid overdose in 2016 and the majority of these deaths (76%) were attributable to pharmaceutical opioids.
NCETA’s Allan Trifonoff and Roger Nicholas are presenting a free one-hour webinar on Wednesday 17 October 2018 about crystal methamphetamine and strategies and resources to support frontline workers.
NDRI is seeking an Indigenous Australian researcher to lead its Aboriginal Australian research program.
NCCRED has announced the first round of funding grants for innovative clinical research for the treatment of substance use disorders due to methamphetamine or emerging drugs of concern.
NDARC's Dr Mieke Snijder was awarded a prestigious Early Career Research Award at the 2018 Mental Health Service Awards of Australia and New Zealand for service to mental health.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Tuesday 15 October 2019